Related Experiment Video
Updated: Feb 16, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Collapsing the Tumor Ecosystem: Preventing Adaptive Response to Treatment by Inhibiting Transcription
Alessandro Carugo1, Giulio F Draetta2
1Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
Adaptation and resistance to treatment are the results of a multitude of (epi)genetic events unmasked or directly triggered by therapies targeting the genetic driver(s) of a dominant cell population within a tumor mass. Rusan and colleagues report that drug-tolerant cells are sensitive to THZ1, a dual CDK7/12 inhibitor, which, by impairing the transcriptional machinery, can prevent cellular rewiring to survive therapeutic attack. Cancer Discov; 8(1); 17-9. ©2018 AACRSee related article by Rusan et al., p. 59.
Insights
Cancer drug resistance emerges from genetic changes. A dual CDK7/12 inhibitor, THZ1, effectively targets drug-tolerant cells by disrupting their transcriptional machinery, preventing survival during therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Cancer therapies often trigger adaptive resistance through epigenetic and genetic events.
- Tumor heterogeneity allows a dominant cell population to survive initial treatment.
Purpose of the Study:
- To investigate novel therapeutic strategies targeting drug-tolerant cancer cells.
- To identify vulnerabilities in cancer cell adaptation mechanisms.
Main Methods:
- Utilized THZ1, a dual Cyclin-Dependent Kinase (CDK) 7/12 inhibitor.
- Assessed the impact of THZ1 on transcriptional machinery in drug-tolerant cells.
Main Results:
- Drug-tolerant cancer cells demonstrated sensitivity to THZ1.
- THZ1 impaired the transcriptional machinery, hindering cellular adaptation.
- Inhibition of transcriptional rewiring prevented therapeutic resistance.
Conclusions:
- THZ1 represents a promising therapeutic agent against drug-tolerant cancer cells.
- Targeting transcriptional regulation is a viable strategy to overcome cancer treatment resistance.
Related Concept Videos
What is an Ecosystem?
The Soil Ecosystem
Cells of the Adaptive Immune Response
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Master Transcription Regulators
Feedback Inhibition

